These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 1910184)

  • 1. Preventing secondary infections among HIV-positive persons.
    Filice GA; Pomeroy C
    Public Health Rep; 1991; 106(5):503-17. PubMed ID: 1910184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world.
    Kaplan JE; Hu DJ; Holmes KK; Jaffe HW; Masur H; De Cock KM
    Am J Trop Med Hyg; 1996 Jul; 55(1):1-11. PubMed ID: 8702012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Kaplan JE; Masur H; Holmes KK; ;
    MMWR Recomm Rep; 2002 Jun; 51(RR-8):1-52. PubMed ID: 12081007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary care of women infected with the human immunodeficiency virus.
    Allen MH
    Obstet Gynecol Clin North Am; 1990 Sep; 17(3):557-69. PubMed ID: 2247290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating opportunistic infections among HIV-exposed and infected children: recommendations from CDC, the National Institutes of Health, and the Infectious Diseases Society of America.
    Mofenson LM; Oleske J; Serchuck L; Van Dyke R; Wilfert C
    Clin Infect Dis; 2005 Feb; 40 Suppl 1():S1-84. PubMed ID: 15655768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current CDC efforts to prevent and control human immunodeficiency virus infection and AIDS in the United States through information and education.
    Mason JO; Noble GR; Lindsey BK; Kolbe LJ; Van Ness P; Bowen GS; Drotman DP; Rosenberg ML
    Public Health Rep; 1988; 103(3):255-60. PubMed ID: 2836879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections].
    Pozio E
    Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Which are the vaccines that human immunodeficiency virus infected patients must receive?].
    Valencia Ortega ME; González Lahoz JM
    An Med Interna; 1998 Aug; 15(8):439-42. PubMed ID: 9780428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV infection and routine childhood immunization: a review.
    Clements CJ; von Reyn CF; Mann JM
    Bull World Health Organ; 1987; 65(6):905-11. PubMed ID: 3325188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Secondary prevention in HIV infection].
    Weber R; Lüthy R
    Ther Umsch; 1991 Apr; 48(4):258-63. PubMed ID: 1858068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America.
    Masur H; Kaplan JE; Holmes KK; ;
    Ann Intern Med; 2002 Sep; 137(5 Pt 2):435-78. PubMed ID: 12617574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a five-step message development model for food safety education materials targeting people with HIV/AIDS.
    Hoffman EW; Bergmann V; Shultz JA; Kendall P; Medeiros LC; Hillers VN
    J Am Diet Assoc; 2005 Oct; 105(10):1597-604. PubMed ID: 16183361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sociodemographic characteristics of HIV infection in northern India.
    Giri TK; Wali JP; Meena HS; Pande I; Uppal S; Kailash S
    J Commun Dis; 1995 Mar; 27(1):1-9. PubMed ID: 7636144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food counseling for persons infected with HIV: strategy for defensive living.
    Archer DL
    Public Health Rep; 1989; 104(2):196-8. PubMed ID: 2495555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
    Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
    J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epidemiology of the acquired immunodeficiency syndrome in the 1990s.
    Quinn TC
    Emerg Med Clin North Am; 1995 Feb; 13(1):1-25. PubMed ID: 7851311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus infection in children: nature of immunodeficiency, clinical spectrum and management.
    Pahwa S
    Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S61-71. PubMed ID: 3041360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food and water safety for persons infected with human immunodeficiency virus.
    Hayes C; Elliot E; Krales E; Downer G
    Clin Infect Dis; 2003 Apr; 36(Suppl 2):S106-9. PubMed ID: 12652380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Travel patterns and risk behaviour of HIV-positive people travelling internationally.
    Salit IE; Sano M; Boggild AK; Kain KC
    CMAJ; 2005 Mar; 172(7):884-8. PubMed ID: 15795409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.